Profound(PROF) - 2025 Q3 - Quarterly Results

Filing Details This section provides the fundamental identification and status information for the Form 8-K filing General Information This section provides the basic identification details of the Form 8-K filing, including the registrant's name, jurisdiction, address, and contact information, along with the date of the report - Company Name: PROFOUND MEDICAL CORP.[1] - Date of Report: October 7, 2025[1] - Jurisdiction of Incorporation: Ontario, Canada[1] Securities and Filing Status This section details the registrant's securities information, specifically common shares traded on Nasdaq, and confirms its status regarding emerging growth company provisions Securities Registered | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :------------------ | :---------------- | :---------------------------------------- | | Common Shares | PROF | The Nasdaq Stock Market | - Emerging growth company status: Not an emerging growth company (indicated by unchecked box)[3] Corporate Event Disclosure This section discloses significant corporate events, including financial results and related exhibits Item 2.02 - Results of Operations and Financial Condition Profound Medical Corp. announced its preliminary unaudited financial results for the three months ended September 30, 2025, along with a business update, via a press release furnished as Exhibit 99.1. The information is not considered 'filed' for Section 18 purposes of the Exchange Act - Event: Announcement of preliminary unaudited financial results for the three months ended September 30, 2025, and a business update[4] - Date of Announcement: October 7, 2025[4] - Source: Press release furnished as Exhibit 99.1[4] - Filing Status: The information in Item 2.02 (including Exhibit 99.1) is furnished, not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934[5] Item 9.01 - Financial Statements and Exhibits This section lists the exhibits accompanying the Form 8-K filing, primarily the press release detailing the financial results and business update, and the interactive data file Exhibits Filed | Exhibit No. | Description | | :---------- | :---------------------------------------------------------- | | 99.1 | Press Release dated October 7, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | Signatures This section formally authenticates the report through the authorized signatory Authorization and Signatory The report is formally signed on behalf of Profound Medical Corp. by its Chief Financial Officer, Rashed Dewan, confirming compliance with the Securities Exchange Act of 1934 requirements - Signatory: Rashed Dewan, Chief Financial Officer[10] - Date of Signature: October 7, 2025[10]